开发一种mRNA疫苗用于引起的脑炎:选择原型病毒菌株
Maria A Nikiforova1, Vladimir A Gushchin1,2,3, Denis A Kleymenov1,2
1Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Vaccines
|January 28, 2026
概括
一种新的mRNA疫苗候选者在小鼠中证明了100%的存活率对传播脑炎病毒 (TBEV) 的挑战. 这种新疫苗显示出对各种TBEV菌株的广泛保护的承诺,解决了当前疫苗的局限性.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 感染性脑炎病毒 (TBEV) 在亚型之间表现出抗原分歧,使疫苗和抗病毒开发复杂化.
- 现有的非活化TBEV疫苗对不同菌株提供了不足的交叉保护.
- 接种疫苗的人群中突破性感染突显了需要更广泛的TBEV免疫力.
研究的目的:
- 设计和评估一种新的mRNA疫苗候选人,用于传播脑炎病毒 (TBEV).
- 评估候选mRNA疫苗引起的免疫性和保护性免疫的范围.
- 调查针对各种TBEV菌株的交叉保护功效.
主要方法:
- 合成了十种信使RNA (mRNA) 候选疫苗,它们编码在脂质纳米颗粒 (LNP) 中封装的TBEV前膜/外 (PrM/E) 蛋白质.
- 通过测量抗原特异性IgG和在BALB/c小鼠中对多个TBEV菌株的中和抗体标位来评估免疫性.
- 通过使用七种不同的TBEV菌株的致命挑战模型来评估保护效果.
主要成果:
- 所有经过测试的mRNA-PrM/E-LNP候选疫苗在面对7种TBEV菌株致命剂量挑战的小鼠中实现了100%的存活率.
- 该mRNA-PrM/E-Krasny Yar-8结构表现出优越的免疫性,具有高抗原特异性IgG GMT的1:6625.
- 这种主要候选体在体外对同源和异源TBEV菌株表现出最广泛的病毒中和活性.
结论:
- mRNA疫苗平台是开发有效的TBEV疫苗的一个非常有前途的战略.
- 候选mRNA疫苗显示出显著的免疫性和广泛的交叉保护疗效,对各种TBEV菌株.
- 这项研究为开发使用mRNA技术的下一代TBEV疫苗提供了坚实的基础.
相关概念视频
The Born-Haber Cycle
25.3K
Lattice Energy
25.3K
Vaccinations
51.5K
Overview
51.5K
Concepts and Prototypes
536
The human nervous system handles vast amounts of information by translating sensory stimuli into neural impulses, which the brain processes, creating thoughts expressed through language or stored as memories. The brain also synthesizes information from emotions and memories, which significantly influence thoughts and behaviors. This intricate process creates a comprehensive mental picture.
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...
536
Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
Nonsense-mediated mRNA Decay
11.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K


